Acalabrutinib

Acalabrutinib is a drug used to treat non-Hodgkin's lymphoma (called set cell lymphoma). In particular, this applies to people who have been previously treated with another therapy 

API&Intermediates CAS Structural formula Drug Minimum order quantity
1 Acalabrutinib 1420477-60-6 API 5g
2 1-Pyrrolidinecarboxylic acid, 2-(8-amino-1-bromoimidazo[1,5- 1420478-88-1 Intermediate 5g
    Contact
  • Company Tel:022-28219283
  • Email:info@holder-pharm.com
Copyright©2020 Tianjin Holder Pharmaceutical Technology Co., Ltd. .All rights reserved.
Address:Building 6, Hengze Industrial Park, Jinnan District, Tianjin